In a recent bid Allscripts Healthcare Solutions Inc. [MDRX] faced a contemporary bid of $10.82 yielding a -0.95% decline where 8.99 million shares have exchanged hands over the last week. MDRX amount got a boost by 30.20% or $2.51 versus $8.31 at the end of the prior session. This change led market cap to move at 1.38B, putting the price 137.28% below the 52-week high and -8.46% above the 52-week low. The company’s stock has a normal trading capacity of 8.99 million shares while the relative volume is 21.96.

Analyst Birdseye View:

The most recent analyst activity for Allscripts Healthcare Solutions Inc. [NASDAQ:MDRX] stock was on April 22, 2020, when it was Downgrade with a Hold rating from Jefferies, which also lowered its 12-month price target on the stock from $10.50 to $7. Before that, on July 21, 2020, Goldman Recapitulated a Sell rating and elevated its amount target to $5.50. On April 21, 2020, RBC Capital Mkts Initiated an Outperform rating and boosted its price target on this stock to $8. On April 13, 2020, SVB Leerink Initiated a Mkt perform rating. On November 26, 2019, UBS Initiated a Neutral rating and increased its price target to $11.50. On September 26, 2019, Deutsche Bank Initiated a Hold rating and boosted its amount on this stock to $11. On February 22, 2019, KeyBanc Capital Markets Downgrade a Sector weight rating.

In the past 52 weeks of trading, this stock has oscillated between a low of $4.56 and a peak of $11.82. Right now, the middling Wall Street analyst 12-month amount mark is $10.00. At the most recent market close, shares of Allscripts Healthcare Solutions Inc. [NASDAQ:MDRX] were valued at $10.82. According to the average price forecast, investors can expect a potential return of 0.3%.


Allscripts Healthcare Solutions Inc. [NASDAQ:MDRX] most recently reported quarterly sales of 406.22 billion, which represented growth of -8.60%. This publicly-traded organization’s revenue is $184,550 per employee, while its income is -$18,977 per employee. This company’s Gross Margin is currently 39.40%, its Operating Margin is -2.80%, its Pretax Margin is -11.66, and its Net Margin is -10.28. Continuing to look at profitability, this corporation’s Return on Assets, Equity, Whole Principal & invested Principal is sitting at -5.70, -12.85, 0.37 and -8.82 respectively.

The Principal structure of this organization shows its whole liability to whole principal at 44.58 and the whole liability to whole assets at 32.25. It shows enduring liability to the whole principal at 27.86 and enduring liability to assets at 0.20 while looking for an extended time period.

Readers are usually of view to make a close observation to the indicators that support and make resistance before moving to any particular stock. As of now, the company’s stock is sitting at 8.20 points at 1st support level, the second support level is making up to 8.08. But as of 1st resistance point, this stock is sitting at 8.48 and at 8.64 for 2nd resistance point.

Allscripts Healthcare Solutions Inc. [MDRX] reported its earnings at $0.18 per share in the fiscal quarter closing of 6/29/2020. The Analysts for Wall Street were expecting to report its earnings at $0.12/share signifying the difference of 0.06 and 50.00% surprise value. Comparing the previous quarter ending of 3/30/2020, the stated earnings were $0.09 calling estimates for $0.15/share with the difference of -0.06 depicting the surprise of -40.00%.

Important Ratio’s To Watch

Meanwhile, turning our focus to liquidity, the Current Ratio for Allscripts Healthcare Solutions Inc. [NASDAQ:MDRX] is 0.80. Likewise, the Quick ratio is also the same, showing Cash ratio at 0.11. Now if looking for a valuation of this stock’s amount to sales ratio it’s 0.92 and it’s amount to book ratio is 1.24.

Insider Stories

The most recent insider trade was by Khorey Lisa, Chief Client Delivery Officer, and it was the sale of 30000.0 shares on Jun 05. Farley Brian, the EVP and CAO, completed a sale of 24000.0 shares on Apr 09. On Mar 05, Poulton Richard J., President & CFO, completed a purchase of 15000.0 shares.